CBOE vs CPHI · P/E 24, $29.50B cap vs rev $4.1M
Cboe Global Markets Inc (CBOE) versus China Pharma Holdings Inc (CPHI) — a side-by-side from cached financials, not a winner call.
Cboe Global Markets Inc (CBOE) is a financial data & stock exchanges company listed on US.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
CBOE does not have a complete income-statement cache yet.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
CBOE currently screens at market cap $29.50B and trailing P/E 24.1. CPHI currently screens at market cap $29.0M.
Not investment advice. Open the CBOE and CPHI stock pages for the full models.
Not investment advice.